List of works - Xavier Durando

A methionine-free diet associated with nitrosourea treatment down-regulates methylguanine-DNA methyl transferase activity in patients with metastatic cancer

scientific article published on 01 July 2007

A new prognostic classification after primary chemotherapy for breast cancer: residual disease in breast and nodes (RDBN)

scientific article published on 01 March 2008

A phase I clinical and pharmacological study evaluating vinflunine in combination with doxorubicin as first line treatment in metastatic breast cancer

scientific article published on 26 March 2011

Achieving higher pathological complete response rates in HER-2-positive patients with induction chemotherapy without trastuzumab in operable breast cancer.

scientific article published on April 2007

Adherence with oral oncologic treatment in cancer patients: interest of an adherence score of all dosing errors

scientific article published on 31 October 2012

Aggressive silent GH pituitary tumor resistant to multiple treatments, including temozolomide

scientific article published on 01 March 2013

Allelic loss of 9p21.3 is a prognostic factor in 1p/19q codeleted anaplastic gliomas

scientific article

Brown adipose tissue activity in relation to weight gain during chemotherapy in breast cancer patients: a pilot study.

scientific article published on 26 August 2014

Can pathologic complete response (pCR) be used as a surrogate marker of survival after neoadjuvant therapy for breast cancer?

scientific article published on 04 March 2015

Changes and predictive and prognostic value of the mitotic index, Ki-67, cyclin D1, and cyclo-oxygenase-2 in 710 operable breast cancer patients treated with neoadjuvant chemotherapy.

scientific article

Changes in and prognostic value of hormone receptor status in a series of operable breast cancer patients treated with neoadjuvant chemotherapy

scientific article published on 01 June 2007

Clinicopathological factors and nomograms predicting nonsentinel lymph node metastases after neoadjuvant chemotherapy in breast cancer patients

scientific article published on 02 May 2009

Comparative review of anastrozole, letrozole and exemestane in the management of early breast cancer

scientific article published on June 2009

Comparison of the prognostic significance of Chevallier and Sataloff's pathologic classifications after neoadjuvant chemotherapy of operable breast cancer.

scientific article published on 10 June 2008

Cystemustine in recurrent high grade glioma.

scientific article published on 31 March 2006

Determination of irinotecan and SN38 in human plasma by TurboFlow™ liquid chromatography-tandem mass spectrometry

scientific article published on 04 November 2015

Dietary methionine restriction with FOLFOX regimen as first line therapy of metastatic colorectal cancer: a feasibility study.

scientific article published on 26 April 2010

Does regional lymph node irradiation improve the outcome of N0 and pN0 breast cancer?

scientific article published on 01 February 2010

Does survival increase in metastatic breast cancer with recently available anticancer drugs?

scientific article published on 01 January 2006

Everolimus in Metastatic Breast Cancer: Clinical Experience as a Late Treatment Line.

scientific article published on 13 October 2015

Hepatic intra-arterial versus intravenous fotemustine in patients with liver metastases from uveal melanoma (EORTC 18021): a multicentric randomized trial

scientific article

Hibernoma: a clinical model for exploring the role of brown adipose tissue in the regulation of body weight?

scientific article published on 20 December 2013

High-dose BCNU followed by autologous hematopoietic stem cell transplantation in supratentorial high-grade malignant gliomas: a retrospective analysis of 114 patients.

scientific article published in April 2003

Importance of metabolic changes induced by chemotherapy on prognosis of early‐stage breast cancer patients: a review of potential mechanisms ⬇️

scientific article published on December 1, 2011

Intraoperative imprint cytology examination of sentinel lymph nodes after neoadjuvant chemotherapy in breast cancer patients

scientific article published on 13 February 2010

Late lines of treatment benefit survival in metastatic breast cancer in current practice?

scientific article published on 17 August 2011

Long-term disease-free survival in advanced melanomas treated with nitrosoureas: mechanisms and new perspectives.

scientific article

Mammalian target of rapamycin inhibitors in combination with letrozole in breast cancer

scientific article published on 01 October 2006

Measurement of residual disease after neoadjuvant chemotherapy

scientific article published on 01 June 2008

Memantine before Mastectomy Prevents Post-Surgery Pain: A Randomized, Blinded Clinical Trial in Surgical Patients

scientific article

Metastatic breast cancer: overall survival related to successive chemotherapies. What do we gain after the third line?

scientific article published on 01 January 2009

Methionine dependency and cancer treatment ⬇️

scientific article published on December 1, 2003

Multicentric neoadjuvant pilot Phase II study of cetuximab combined with docetaxel in operable triple negative breast cancer.

scientific article published on 28 December 2015

Neoadjuvant endocrine therapy in breast cancer

scientific article published on 17 October 2005

Neurotoxicity as a prognostic factor in patients with metastatic breast cancer treated with ixabepilone as a first-line therapy

scientific article published on 27 November 2014

O-Mel-Inib: a Cancéro-pôle Nord-Ouest multicenter phase II trial of high-dose imatinib mesylate in metastatic uveal melanoma.

scientific article published on 13 June 2008

Optimal methionine-free diet duration for nitrourea treatment: a Phase I clinical trial

scientific article published in January 2008

Peritoneal mesothelioma: long survival with intraperitoneal chemotherapy, lanreotide and mucolytics

scientific article

Potential allogeneic graft-versus-tumor effect in a patient with ovarian cancer

scientific article published on 01 March 2000

Prediction of overall survival through circadian rest-activity monitoring during chemotherapy for metastatic colorectal cancer.

scientific article published on 3 July 2012

Prognostic value of initial tumor parameters after metastatic relapse

scientific article published on 01 November 2011

Radiotherapy plus temozolomide in elderly patients with glioblastoma: a "real-life" report

scientific article published on 6 December 2017

Randomized phase II trial of irinotecan and bevacizumab as neo-adjuvant and adjuvant to temozolomide-based chemoradiation compared with temozolomide-chemoradiation for unresectable glioblastoma: final results of the TEMAVIR study from ANOCEF†.

scientific article

Role of aromatase inhibitors in the upfront adjuvant hormonal therapy of postmenopausal patients with breast cancer ⬇️

scientific article published on August 7, 2010

Second-line chemotherapy of disseminated malignant melanoma with cystemustine at 60 mg/m2: a phase II trial

scientific article

Sentinel lymph node biopsy after neoadjuvant chemotherapy is accurate in breast cancer patients with a clinically negative axillary nodal status at presentation

scientific article published on 01 March 2008

Temozolomide and unusual indications: review of literature.

scientific article published on 19 July 2012

Temozolomide treatment of an adult with a relapsing medulloblastoma.

scientific article published in September 2007

The New Combination Docetaxel, Prednisone and Curcumin in Patients with Castration-Resistant Prostate Cancer: A Pilot Phase II Study

scientific article

Therapeutic drug monitoring and tyrosine kinase inhibitors

scientific article published on 24 June 2016

Vaginal Lymphoma: A Possible Cause of Genital Hemorrhage.

scientific article published on 18 April 2016

Waiting times before initiation of radiotherapy might not affect outcomes for patients with glioblastoma: a French retrospective analysis of patients treated in the era of concomitant temozolomide and radiotherapy

scientific article published on 2 June 2012

Weekly paclitaxel as a single agent or in combination with carboplatin or weekly topotecan in patients with resistant ovarian cancer: the CARTAXHY randomized phase II trial from Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens (GI

scientific article published on 11 May 2011

Weight change during chemotherapy changes the prognosis in non metastatic breast cancer for the worse.

scientific article published on 25 November 2010

What is your diagnosis?

scientific article published on 01 December 2014

[Elderly patients with glioblastoma: state of the art]

scientific article published on 27 February 2015

[Indications, contra-indications, expected results and choice of neoadjuvant chemotherapy for operable breast cancer]

scientific article published on 01 November 2006

[Management of a patient with cancer during all stages of the disease. Symptomatic treatment. Modalities of surveillance. Psychological, ethical and social problems]

scientific article published on 01 November 2004

[Poor prognostic value of weight change during chemotherapy in non-metastatic breast cancer patients: causes, mechanisms involved and preventive strategies]

scientific article published on 01 September 2013

[Prognostic value of epidermal growth factor receptor]

scientific article published on 01 November 2003

[Therapeutic strategies and systemic treatment of brain melanoma metastases].

scientific article

List of works by Xavier Durando

A methionine-free diet associated with nitrosourea treatment down-regulates methylguanine-DNA methyl transferase activity in patients with metastatic cancer

A new prognostic classification after primary chemotherapy for breast cancer: residual disease in breast and nodes (RDBN)

A phase I clinical and pharmacological study evaluating vinflunine in combination with doxorubicin as first line treatment in metastatic breast cancer

Achieving higher pathological complete response rates in HER-2-positive patients with induction chemotherapy without trastuzumab in operable breast cancer.

Adherence with oral oncologic treatment in cancer patients: interest of an adherence score of all dosing errors

Aggressive silent GH pituitary tumor resistant to multiple treatments, including temozolomide

Allelic loss of 9p21.3 is a prognostic factor in 1p/19q codeleted anaplastic gliomas

Brown adipose tissue activity in relation to weight gain during chemotherapy in breast cancer patients: a pilot study.

Can pathologic complete response (pCR) be used as a surrogate marker of survival after neoadjuvant therapy for breast cancer?

Changes and predictive and prognostic value of the mitotic index, Ki-67, cyclin D1, and cyclo-oxygenase-2 in 710 operable breast cancer patients treated with neoadjuvant chemotherapy.

Changes in and prognostic value of hormone receptor status in a series of operable breast cancer patients treated with neoadjuvant chemotherapy

Clinicopathological factors and nomograms predicting nonsentinel lymph node metastases after neoadjuvant chemotherapy in breast cancer patients

Comparative review of anastrozole, letrozole and exemestane in the management of early breast cancer

Comparison of the prognostic significance of Chevallier and Sataloff's pathologic classifications after neoadjuvant chemotherapy of operable breast cancer.

Cystemustine in recurrent high grade glioma.

Determination of irinotecan and SN38 in human plasma by TurboFlow™ liquid chromatography-tandem mass spectrometry

Dietary methionine restriction with FOLFOX regimen as first line therapy of metastatic colorectal cancer: a feasibility study.

Does regional lymph node irradiation improve the outcome of N0 and pN0 breast cancer?

Does survival increase in metastatic breast cancer with recently available anticancer drugs?

Everolimus in Metastatic Breast Cancer: Clinical Experience as a Late Treatment Line.

Hepatic intra-arterial versus intravenous fotemustine in patients with liver metastases from uveal melanoma (EORTC 18021): a multicentric randomized trial

Hibernoma: a clinical model for exploring the role of brown adipose tissue in the regulation of body weight?

High-dose BCNU followed by autologous hematopoietic stem cell transplantation in supratentorial high-grade malignant gliomas: a retrospective analysis of 114 patients.

Importance of metabolic changes induced by chemotherapy on prognosis of early‐stage breast cancer patients: a review of potential mechanisms ⬇️

Intraoperative imprint cytology examination of sentinel lymph nodes after neoadjuvant chemotherapy in breast cancer patients

Late lines of treatment benefit survival in metastatic breast cancer in current practice?

Long-term disease-free survival in advanced melanomas treated with nitrosoureas: mechanisms and new perspectives.

Mammalian target of rapamycin inhibitors in combination with letrozole in breast cancer

Measurement of residual disease after neoadjuvant chemotherapy

Memantine before Mastectomy Prevents Post-Surgery Pain: A Randomized, Blinded Clinical Trial in Surgical Patients

Metastatic breast cancer: overall survival related to successive chemotherapies. What do we gain after the third line?

Methionine dependency and cancer treatment ⬇️

Multicentric neoadjuvant pilot Phase II study of cetuximab combined with docetaxel in operable triple negative breast cancer.

Neoadjuvant endocrine therapy in breast cancer

Neurotoxicity as a prognostic factor in patients with metastatic breast cancer treated with ixabepilone as a first-line therapy

O-Mel-Inib: a Cancéro-pôle Nord-Ouest multicenter phase II trial of high-dose imatinib mesylate in metastatic uveal melanoma.

Optimal methionine-free diet duration for nitrourea treatment: a Phase I clinical trial

Peritoneal mesothelioma: long survival with intraperitoneal chemotherapy, lanreotide and mucolytics

Potential allogeneic graft-versus-tumor effect in a patient with ovarian cancer

Prediction of overall survival through circadian rest-activity monitoring during chemotherapy for metastatic colorectal cancer.

Prognostic value of initial tumor parameters after metastatic relapse

Radiotherapy plus temozolomide in elderly patients with glioblastoma: a "real-life" report

Randomized phase II trial of irinotecan and bevacizumab as neo-adjuvant and adjuvant to temozolomide-based chemoradiation compared with temozolomide-chemoradiation for unresectable glioblastoma: final results of the TEMAVIR study from ANOCEF†.

Role of aromatase inhibitors in the upfront adjuvant hormonal therapy of postmenopausal patients with breast cancer ⬇️

Second-line chemotherapy of disseminated malignant melanoma with cystemustine at 60 mg/m2: a phase II trial

Sentinel lymph node biopsy after neoadjuvant chemotherapy is accurate in breast cancer patients with a clinically negative axillary nodal status at presentation

Temozolomide and unusual indications: review of literature.

Temozolomide treatment of an adult with a relapsing medulloblastoma.

The New Combination Docetaxel, Prednisone and Curcumin in Patients with Castration-Resistant Prostate Cancer: A Pilot Phase II Study

Therapeutic drug monitoring and tyrosine kinase inhibitors

Vaginal Lymphoma: A Possible Cause of Genital Hemorrhage.

Waiting times before initiation of radiotherapy might not affect outcomes for patients with glioblastoma: a French retrospective analysis of patients treated in the era of concomitant temozolomide and radiotherapy

Weekly paclitaxel as a single agent or in combination with carboplatin or weekly topotecan in patients with resistant ovarian cancer: the CARTAXHY randomized phase II trial from Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens (GI

Weight change during chemotherapy changes the prognosis in non metastatic breast cancer for the worse.

What is your diagnosis?

[Elderly patients with glioblastoma: state of the art]

[Indications, contra-indications, expected results and choice of neoadjuvant chemotherapy for operable breast cancer]

[Management of a patient with cancer during all stages of the disease. Symptomatic treatment. Modalities of surveillance. Psychological, ethical and social problems]

[Poor prognostic value of weight change during chemotherapy in non-metastatic breast cancer patients: causes, mechanisms involved and preventive strategies]

[Prognostic value of epidermal growth factor receptor]

[Therapeutic strategies and systemic treatment of brain melanoma metastases].